We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Downstream Hatch-Waxman: Unforeseen IP Ramifications

Law360 (July 19, 2005, 12:00 AM EDT) -- Litigation challenging patents on branded drugs has increased exponentially since the passage of the Drug Price Competition and Patent Term Restoration Act of 1984 (commonly referred to as the "Hatch Waxman...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.